MSN: Combo therapy for head and neck cancer

UC researchers tested a new combination therapy showing reduced growth of head and neck cancer

UC researchers have tested a new combination therapy that showed reduced growth of head and neck cancer in an animal-based study. These results were published in the journal Cancer Letters.

Christina Wicker, PhD, a postdoctoral fellow in the lab of Vinita Takiar, MD, PhD, led this research and says head and neck cancer is the sixth most common cancer worldwide.

"Head and neck cancer, like any cancer, is truly life-altering. Head and neck cancer could impact your throat, tongue or nose and patients often can't swallow, talk or eat; it truly takes away some of the most social, enjoyable parts of life," she says.

"Until now, no one has examined if this drug has the potential to improve radiation treatment in head and neck cancer."

Read the full MSN article.

Read the UC News story about Wicker's research.

Featured photo of Christina Wicker working in the lab by Colleen Kelley. 

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.